Company / SG&A Expense
DIVERSIFIED HEALTHCARE TRUST SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$45.5M
FY2025
5-year range
$26.1M / $45.5M
FY2021-FY2025
Trend
+71.6%
vs FY2024
Sector context
#83 of 131
Real Estate
What the data says
At $46M, DIVERSIFIED HEALTHCARE TRUST's sg&a expense ranks #49 of 131 in the Real Estate sector. SG&A Expense has fluctuated over the past 10 years, ranging from $26M in FY2023 to $104M in FY2019.
Based on SEC 10-K filings.
$46M in FY2025 with a 5-year CAGR of -11.9%.
Increased from $26M to $46M over the past 2 years.
Real Estate sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +19.8%
- 5-Year CAGR
- -11.9%
- 10-Year CAGR
- -
Sector benchmark
#49 of 131 in Real EstateTop 37% of 131This company $45.5M Sector average $159.5M
▼
-71.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.9%, indicating a declining trend.
- In FY2025, sg&a expense increased 71.6% year-over-year.
- Ranks #83 out of 131 companies in the Real Estate sector.
- Peak sg&a expense was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.83 (distress zone, below 1.8 threshold)
- Negative profit margin: -24.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.5M | +71.6% |
| FY2024 | $26.5M | +1.5% |
| FY2023 | $26.1M | -1.1% |
| FY2022 | $26.4M | -22.4% |
| FY2021 | $34.1M | -60.3% |
| FY2020 | $85.9M | -17.2% |
| FY2019 | $103.7M | +20.7% |
| FY2018 | $85.9M | -17.2% |
| FY2017 | $103.7M | +122.7% |
| FY2016 | $46.6M | +8.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026